Maine advocates seek Medicare coverage for anti-obesity medications to improve public health, reduce healthcare costs, and promote active transportation. Bipartisan support grows with Senator Susan Collins' leadership.
Analysis of the Trump administration's increased use of executive power, constitutional implications, impact on economic policy, and market stability risks.
Medicare Advantage enrollment growth slows in 2025 with for-profit plans covering three-quarters of beneficiaries. Quality ratings decline and workforce shortages drive interest in advanced practice providers and AI solutions.
CMS finalizes key elements of the CY 2026 Medicare Advantage and Medicare Part D final rule, including insulin coverage expansion, Prescription Payment Plan codification, pharmacy data requirements, and updated enrollee protections.
CMS increases 2026 Medicare Advantage reimbursement rates to 5.06%, easing insurer pressures while adjusting policies on obesity drug coverage and billing practices.
CMS drives healthcare efficiency with initiatives like the HL7 FHIR Connectathon, Oklahoma directory pilot, HIPAA updates, and new prior authorization rules for Medicare and Medicaid.
UnitedHealth Group's Q1 2025 earnings reveal increased Medicare Advantage care utilization and regulatory payment changes impacting financial performance, highlighting challenges in the evolving health insurance market.
Summary of Trump's executive order directing HHS to reduce prescription drug costs, focusing on Medicare reimbursement for 340B drugs, IRA drug pricing provisions, and CMS premium stabilization efforts.
Medicare Part B now covers a wide range of telehealth services, enhancing healthcare access for millions of beneficiaries via virtual care platforms offering primary and urgent care nationwide.
Federal budget cuts targeting Medicare and Medicaid create challenges for Arizona's healthcare system, threatening rural hospitals and vulnerable populations dependent on AHCCCS coverage.
